These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 17016656

  • 1. Suppression of SCC antigen promotes cancer cell invasion and migration through the decrease in E-cadherin expression.
    Murakami A, Nakagawa T, Kaneko M, Nawata S, Takeda O, Kato H, Sugino N.
    Int J Oncol; 2006 Nov; 29(5):1231-5. PubMed ID: 17016656
    [Abstract] [Full Text] [Related]

  • 2. E-cadherin increases squamous cell carcinoma antigen expression through phosphatidylinositol-3 kinase-Akt pathway in squamous cell carcinoma cell lines.
    Nakagawa T, Murakami A, Torii M, Nawata S, Takeda O, Sugino N.
    Oncol Rep; 2007 Jul; 18(1):175-9. PubMed ID: 17549365
    [Abstract] [Full Text] [Related]

  • 3. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
    Murakami A, Nakagawa T, Fukushima C, Torii M, Sueoka K, Nawata S, Takeda O, Ishikawa H, Sugino N.
    Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
    [Abstract] [Full Text] [Related]

  • 4. Regulation of squamous cell carcinoma antigen production by E-cadherin mediated cell-cell adhesion in squamous cell carcinoma cell line.
    Hirakawa H, Nawata S, Sueoka K, Murakami A, Takeda O, Numa F, Kato H, Sugino N.
    Oncol Rep; 2004 Feb; 11(2):415-9. PubMed ID: 14719077
    [Abstract] [Full Text] [Related]

  • 5. Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines.
    Sueoka K, Nawata S, Nakagawa T, Murakami A, Takeda O, Suminami Y, Kato H, Sugino N.
    Int J Oncol; 2005 Nov; 27(5):1345-53. PubMed ID: 16211231
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K, Ichinose S, Koike R, Kubota T, Yamaguchi M, Miyasaka M, Aso T.
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen.
    Iwasaki M, Nishikawa A, Akutagawa N, Fujimoto T, Teramoto M, Sakaguchi Y, Kato H, Ito M, Yoshida K, Kudo R.
    Exp Cell Res; 2004 Oct 01; 299(2):525-32. PubMed ID: 15350549
    [Abstract] [Full Text] [Related]

  • 9. Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors.
    Moersig W, Horn S, Hilker M, Mayer E, Oelert H.
    Thorac Cardiovasc Surg; 2002 Feb 01; 50(1):45-8. PubMed ID: 11847604
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer.
    Oshikiri T, Miyamoto M, Hiraoka K, Shichinohe T, Kawarada Y, Kato K, Suzuoki M, Nakakubo Y, Kondo S, Dosaka-Akita H, Kasahara N, Katoh H.
    Cancer Gene Ther; 2006 Sep 01; 13(9):856-63. PubMed ID: 16710347
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. E-cadherin expression: a counterbalance for cancer cell invasion.
    Mareel M, Vleminckx K, Vermeulen S, Bracke M, Van Roy F.
    Bull Cancer; 1992 Sep 01; 79(4):347-55. PubMed ID: 1421692
    [Abstract] [Full Text] [Related]

  • 14. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J, Kriajevska M, Berditchevski F, Bronstein I, Lukanidin EM, Pringle JH, Mellon JK, Tulchinsky EM.
    Exp Cell Res; 2007 Jan 15; 313(2):380-93. PubMed ID: 17141758
    [Abstract] [Full Text] [Related]

  • 15. Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy.
    Hsu KF, Wu CL, Huang SC, Hsieh JL, Huang YS, Chen YF, Shen MR, Chung WJ, Chou CY, Shiau AL.
    Cancer Gene Ther; 2008 Aug 15; 15(8):526-34. PubMed ID: 18497852
    [Abstract] [Full Text] [Related]

  • 16. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K, Flechtenmacher C, Angel P, Hess J.
    Cancer Res; 2007 Sep 01; 67(17):8198-206. PubMed ID: 17804733
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I, Andò S.
    Cancer Res; 2007 Apr 01; 67(7):3412-21. PubMed ID: 17409452
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.